Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

26.41
Delayed Data
As of Sep 01
 -0.38 / -1.42%
Today’s Change
9.00
Today|||52-Week Range
35.50
+78.33%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close26.79
Today’s open25.88
Day’s range25.58 - 28.00
Volume345,312
Average volume (3 months)256,862
Market cap$574.1M
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)-41.98%
Earnings growth (this year)--
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+59.05%
P/E ratio--
Price/Sales40.80
Price/Book9.29

Competitors

 Today’s
change
Today’s
% change
ANIPANI Pharmaceuticals ...+1.59+3.26%
NDRMNeuroderm Ltd-0.03-0.12%
AGENAgenus Inc-0.22-3.09%
XBITXBiotech Inc-1.52-7.92%
Data as of 09/01/2015

Financials

Next reporting dateNovember 30, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$6.2M
Annual profit (last year)-$49.1M
Net profit margin-790.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Jörn Aldag
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers